View source for Template:Available forms of testosterone

{| class="wikitable floatright" style="width:600px; font-size:small;"
|+ class="nowrap" style="font-size:105%;" | {{Navbar|Available forms of testosterone|mini=y}} Available forms of [[testosterone (medication)|testosterone]]{{efn|group=testforms|This table does not include combination products with other medications/hormones. The availability of specific products may vary by country - see [[Testosterone (medication)#Availability|Testosterone (medication) § Availability]].}}
|-
! scope="col" | Route
! scope="col" | Ingredient
! scope="col" | Form 
! scope="col" style="width:135px;" | Dose{{efn|group=testforms|These dosages may be given at varying frequencies - dosages listed are "each" (ex: per tablet, per spray, etc) and not indicative of total daily dose or equivalent.}}
! scope="col" font-size:95%;" | Brand names{{efn|group=testforms|Other brand names may be currently or historically marketed.}}
|-
! scope="row" | [[Oral administration|Oral]]
| {{No selflink|Testosterone undecanoate|Test. undecanoate}} || Capsule || 40&nbsp;mg || Andriol, Jatenzo
|-
! scope="row" | [[Sublingual administration|Sublingual]]
| {{No selflink|Testosterone (medication)|Testosterone}} || Tablet || 10&nbsp;mg || Testoral
|-
! scope="row" | [[Buccal administration|Buccal]]
| {{No selflink|Testosterone (medication)|Testosterone}} || Tablet || 30&nbsp;mg || Striant
|-
! scope="row" | [[Intranasal administration|Intranasal]]
| {{No selflink|Testosterone (medication)|Testosterone}} || Nasal gel || style="font-size:90%;" | 5.5&nbsp;mg/spray, 120 sprays || Natesto
|-
! scope="row" rowspan="5" | [[Transdermal administration|Transdermal]]
| rowspan="5" | {{No selflink|Testosterone (medication)|Testosterone}} || Non-scrotal patch || 2.5, 4, 5, 6&nbsp;mg/day || Androderm
|-
| Non-scrotal patch || 150, 300&nbsp;μg/day || Intrinsa
|-
| Scrotal patch{{efn|group=testforms|name=dc|Potentially discontinued.}} || 4, 6&nbsp;mg/day || Testoderm
|-
| Topical gel || 25, 50, 75, 100, 125&nbsp;mg/pump || AndroGel, Testim
|-
| Axillary solution || 30&nbsp;mg/pump || Axiron
|-
! scope="row" | [[Rectal administration|Rectal]]
| {{No selflink|Testosterone (medication)|Testosterone}} || Suppository || 40&nbsp;mg || Rektandron
|-
! scope="row" rowspan="4" | [[Injection (medicine)|Injection]]{{efn|group=testforms|May be by [[intramuscular injection]] or [[subcutaneous injection]].}}
| {{No selflink|Testosterone enanthate|Test. enanthate}} || Oil solution || 50, 100, 180, 200, 250&nbsp;mg/mL || Delatestryl
|-
| {{No selflink|Testosterone cypionate|Test. cypionate}} || Oil solution || style="font-size:93%;" | 50, 100, 200, 250&nbsp;mg/mL || Depo-Testosterone
|-
| style="font-size:100%;" | {{No selflink|Testosterone propionate/testosterone phenylpropionate/testosterone isocaproate/testosterone decanoate|Mixed test. esters}}{{efn|group=testforms|Combination of testosterone propionate, testosterone phenylpropionate, testosterone isocaproate, and testosterone decanoate.}} || Oil solution || 100, 250&nbsp;mg/mL || Sustanon
|-
| {{No selflink|Testosterone undecanoate|Test. undecanoate}} || Oil solution || 750, 1000&nbsp;mg || Aveed, Nebido
|-
! scope="row" | [[Subcutaneous implant|Implant]]
| {{No selflink|Testosterone (medication)|Testosterone}} || Pellet || 50, 75, 100, 200&nbsp;mg || Testopel
|- class="sortbottom"
| colspan="6" style="width: 1px; background-color:#eaecf0; text-align: center;" | {{hidden|header='''Footnotes and sources:'''|content={{noteslist|group=testforms}}
Sources: <ref name="pmid16918944">{{cite journal | vauthors = Nieschlag E | title = Testosterone treatment comes of age: new options for hypogonadal men | journal = Clin. Endocrinol. (Oxf) | volume = 65 | issue = 3 | pages = 275–81 | date = September 2006 | pmid = 16918944 | doi = 10.1111/j.1365-2265.2006.02618.x }}</ref><ref name="pmid25617174">{{cite journal | vauthors = Nieschlag E | title = Current topics in testosterone replacement of hypogonadal men | journal = Best Pract. Res. Clin. Endocrinol. Metab. | volume = 29 | issue = 1 | pages = 77–90 | date = January 2015 | pmid = 25617174 | doi = 10.1016/j.beem.2014.09.008 }}</ref><ref name="pmid12906378">{{cite journal | vauthors = Byrne M, Nieschlag E | title = Testosterone replacement therapy in male hypogonadism | journal = J. Endocrinol. Invest. | volume = 26 | issue = 5 | pages = 481–9 | date = May 2003 | pmid = 12906378 | doi = 10.1007/bf03345206 }}</ref><ref name="CappaCianfarani2015">{{cite book| vauthors = Cappa M, Cianfarani S, Ghizzoni L, Loche S, Maghnie M |title=Advanced Therapies in Pediatric Endocrinology and Diabetology: Workshop, Rome, October 2014|url=https://books.google.com/books?id=myNRCwAAQBAJ&pg=PA68|date=10 December 2015|publisher=Karger Medical and Scientific Publishers|isbn=978-3-318-05637-2|pages=68–}}</ref><ref name="Drugs@FDA">{{cite web |title=Drugs@FDA: FDA Approved Drug Products |publisher=United States Food and Drug Administration |access-date=16 November 2016 |url=http://www.accessdata.fda.gov/scripts/cder/daf/ |url-status=live |archive-url=https://web.archive.org/web/20161116164727/http://www.accessdata.fda.gov/scripts/cder/daf/ |archive-date=November 16, 2016 |df=mdy-all }}</ref><ref name="Melmed2016">{{cite book| vauthors = Melmed S |title=Williams Textbook of Endocrinology|url=https://books.google.com/books?id=YZ8_CwAAQBAJ&pg=PA762|date=1 January 2016|publisher=Elsevier Health Sciences|isbn=978-0-323-29738-7|pages=760–769}}</ref><ref name="Lenehan2003">{{cite book| vauthors = Lenehan P |title=Anabolic Steroids|url=https://books.google.com/books?id=TOePv6WpruQC&pg=PA108|date=12 June 2003|publisher=CRC Press|isbn=978-0-415-28029-7|pages=108–109}}</ref><ref name="Becker2001">{{cite book | vauthors = Becker KL | title = Principles and Practice of Endocrinology and Metabolism | url = https://books.google.com/books?id=FVfzRvaucq8C&pg=PA1182 | year = 2001 | publisher = Lippincott Williams & Wilkins | isbn = 978-0-7817-1750-2 | pages = 1116, 1119, 1152, 1182–1185, 1195–1197, 2146 | url-status = live | archive-url = https://web.archive.org/web/20170505210814/https://books.google.com/books?id=FVfzRvaucq8C&pg=PA1182 | archive-date = May 5, 2017 | df = mdy-all }}</ref><ref name="NieschlagBehre2012">{{cite book | vauthors = Nieschlag E, Behre HM | title = Testosterone: Action - Deficiency - Substitution|url=https://books.google.com/books?id=jn3nCAAAQBAJ&pg=PA350|date=6 December 2012|publisher=Springer Science & Business Media |isbn=978-3-642-72185-4|pages=1–,9,298,309–331,349–353,366–367}}</ref><ref name="KrishnaShah1996">{{cite book| vauthors = Krishna UR, Sheriar NR, Mandecklar A |title=Menopause|url=https://books.google.com/books?id=n16P1r9cBG8C&pg=PA70|year=1996|publisher=Orient Blackswan|isbn=978-81-250-0910-8|pages=70–}}</ref><ref name="Brotherton1976">{{cite book| vauthors = Brotherton J |title=Sex Hormone Pharmacology|url=https://books.google.com/books?id=zt5sAAAAMAAJ|year=1976|publisher=Academic Press|isbn=978-0-12-137250-7|pages=18–19,331,336}}</ref><ref name="WellsDiPiro2014">{{cite book| vauthors = Wells BG, DiPiro JT, Schwinghammer TL, DiPiro CV |title=Pharmacotherapy Handbook, 9/E|url=https://books.google.com/books?id=BMJiAwAAQBAJ|date=22 August 2014|publisher=McGraw-Hill Education|isbn=978-0-07-182129-2|page=288}}</ref><ref name="Lauritzen1988">{{cite book | vauthors = Lauritzen C | chapter = Natürliche und Synthetische Sexualhormone – Biologische Grundlagen und Behandlungsprinzipien | pages = 229–306 | trans-chapter = Natural and Synthetic Sexual Hormones – Biological Basis and Medical Treatment Principles | veditors = Schneider HP, Lauritzen C, Nieschlag E | title = Grundlagen und Klinik der Menschlichen Fortpflanzung | trans-title = Foundations and Clinic of Human Reproduction | language = de | year = 1988 | publisher = Walter de Gruyter | isbn = 978-3110109689 | oclc = 35483492 | url = https://books.google.com/books?id=v4HvAQAACAAJ}}</ref><ref name="Apotekens1964">{{cite book|author=Apotekens informationsavdelning|title=Apotekens synonymregister över farmacevtiska specialiteter|url=https://books.google.com/books?id=uTw8AQAAIAAJ|year=1964|publisher=Apotekens informationsavdelning.|quote=Rektandron FERRING supp. 40 mg • individ. dos. • 10 st.}}</ref>}}
|}<!--

--><noinclude>{{Documentation|content=
==See also==
* [[Testosterone (medication)#Available forms|Testosterone (medication) § Available forms]]
* [[Pharmacokinetics of testosterone#Routes of administration|Pharmacokinetics of testosterone § Routes of administration]]
* [[Template:Available forms of estradiol]]
* [[Template:Available forms of progesterone]]

==References==
{{Reflist}}
}}
[[Category:Medication templates]]
[[Category:Templates that generate named references]]
</noinclude>